The Department of Justice recently announced a new federal-state partnership with Ohio designed to enhance the detection, investigation, and prosecution of fraud. The initiative represents one of the first major enforcement actions involving DOJ's National Fraud Enforcement Division, created in April 2025, and offers an early indication of how the Department intends to deploy its resources in the coming years. The partnership is tied to President Trump's Task Force to Eliminate Fraud, chaired by Vice President Vance, signaling sustained institutional backing for this enforcement model.

The announcement encompasses a broad range of fraud types, including healthcare fraud, government program fraud, and consumer fraud schemes. While traditional healthcare fraud remains a core component of the initiative, the announcement makes clear that the Fraud Division's mandate extends across the full spectrum of fraud against the government and the public.

The partnership introduces several concrete enforcement mechanisms. The Fraud Division and the Ohio Secretary of State announced a data sharing agreement providing the Division access to corporate registrant data, enabling proactive data analysis to identify ownership links between clinics, labs, and billing entities that may be used to obscure control. The Ohio Attorney General's Medicaid Fraud Control Unit reaffirmed its commitment to cross-designate prosecutors to the Fraud Division's Health Care Fraud Strike Forces and deconflict with federal partners on new investigations monthly. CMS is working with Ohio to identify Medicaid fraud and refer criminal matters through its Health Care Fraud Data Fusion Center. The announcement also features the creation of the FBI's "Most Wanted Fraudsters" program, a new initiative to publicize fugitives and enlist public assistance in apprehending them.

From a strategic perspective, DOJ leadership described this explicitly as "a replicable model to combat the full range of fraudsters that are preying on Americans across the country," and the Department has encouraged every state to partner on similar efforts. For companies, this development reinforces a broader trend: enforcement agencies are increasingly working across jurisdictions to identify and investigate suspected fraud more efficiently and comprehensively. Newly created enforcement units are often under pressure to demonstrate results, and companies should expect the Division to seek additional opportunities to generate impactful investigations and prosecutions. One likely avenue will be the expansion of similar federal-state partnerships in other jurisdictions, particularly where state agencies can contribute local expertise, investigative resources, and access to relevant data.

Healthcare providers, managed care organizations, pharmaceutical and medical device companies, government program participants, and other recipients of federal funds should anticipate continued and intensified scrutiny. The data sharing agreement with the Ohio Secretary of State demonstrates that DOJ is investing in the infrastructure to identify suspicious corporate structures proactively, rather than relying solely on tips and referrals. Compliance programs should remain focused on billing integrity, documentation supporting claims for payment, internal reporting mechanisms, prompt investigation of potential issues, and accurate representations in connection with any government benefit program. More broadly, the initiative signals that DOJ intends to use the National Fraud Enforcement Division as a vehicle to drive fraud enforcement through data analytics, interagency cooperation, and expanded federal-state collaboration. For organizations operating in the healthcare sector, receiving government program funds, or interacting with federal benefit programs, the message is clear: fraud enforcement is a top priority with political backing at the highest levels, federal and state authorities are increasingly aligned in pursuing it, and the tools available to investigators are becoming more sophisticated.